Institutions / SilverArc Capital Management, LLC / Holdings
Back to SilverArc Capital Management, LLC

SilverArc Capital Management, LLC

All holdings · as of Dec 31, 2025

64 positions

CompanyClassValueShares% of portfolio
ROCKET PHARMACEUTICALS INC—$2.5K104,8280.0%
iBio, Inc.IBIOCommon Stock$204.6K106,0000.0%
PALISADE BIO, INC.—$240.0K102,1080.0%
Rapport Therapeutics, Inc.RAPPCommon Stock$293.1K9,6590.0%
Adagio Medical Holdings, Inc.—$536.0K515,3840.1%
4D MOLECULAR THERAPEUTICS, INC.—$750.0K100,0000.1%
RADIOPHARM THERANOSTICS LIMITEDRADXADR$978.3K187,4060.1%
Edgewise Therapeutics, Inc.—$1.04M42,0520.2%
X4 Pharmaceuticals, Inc—$1.43M357,3870.2%
CytomX Therapeutics, Inc.—$1.64M385,9740.2%
Sionna Therapeutics, Inc.—$1.71M41,4600.2%
ELUTIA INC.ELUTCommon Stock$1.91M2,751,3140.3%
NextCure, Inc.NXTCCommon Stock$2.50M176,0570.4%
Kymera Therapeutics, Inc.—$2.69M34,5890.4%
TARSUS PHARMACEUTICALS, INC.—$2.96M36,1240.4%
UNIQURE NV—$3.02M126,0470.4%
TELA Bio, Inc.—$3.12M2,647,5120.5%
ABEONA THERAPEUTICS INC.—$3.31M627,7380.5%
Relay Therapeutics, Inc.—$3.37M398,1670.5%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$3.45M94,9830.5%
Contineum Therapeutics, Inc.—$3.52M307,5400.5%
Surrozen, Inc./DESRZNCommon Stock$3.56M157,3230.5%
C4 Therapeutics, Inc.CCCCCommon Stock$3.81M1,994,2240.6%
Aardvark Therapeutics, Inc.AARDCommon Stock$3.99M303,9390.6%
Fulcrum Therapeutics, Inc.—$4.46M394,6500.6%
Erasca, Inc.ERASCommon Stock$4.90M1,317,5840.7%
Olema Pharmaceuticals, Inc.—$5.16M206,2800.7%
Celldex Therapeutics, Inc.—$5.19M191,0740.8%
COMPUGEN LTD—$5.32M3,479,8050.8%
SOLENO THERAPEUTICS, INC.—$5.44M117,4850.8%
Compass Therapeutics, Inc.—$5.65M1,051,3430.8%
CERUS CORP—$5.80M2,814,3830.8%
Amylyx Pharmaceuticals, Inc.—$6.12M506,2420.9%
Lexeo Therapeutics, Inc.—$6.13M617,6080.9%
SPYRE THERAPEUTICS, INC.—$6.15M187,7370.9%
Gossamer Bio, Inc.—$6.62M2,135,7221.0%
Trevi Therapeutics, Inc.—$6.78M541,2401.0%
VAXCYTE, INC.—$6.87M148,7871.0%
Oric Pharmaceuticals, Inc.—$9.13M1,116,6041.3%
Guardant Health, Inc.—$9.39M91,9141.4%
Avalo Therapeutics, Inc.—$9.52M524,4361.4%
Benitec Biopharma Inc.BNTCCommon Stock$9.86M731,7171.4%
PFIZER INC—$10.44M419,1341.5%
ASCENDIS PHARMA A/S—$10.50M49,2281.5%
Viridian Therapeutics, Inc.—$10.85M348,5691.6%
CENTESSA PHARMACEUTICALS PLC—$11.46M458,2031.7%
INSMED INC—$12.40M71,2561.8%
BIOGEN INC.—$13.27M75,4121.9%
Syndax Pharmaceuticals Inc—$13.51M642,8992.0%
RHYTHM PHARMACEUTICALS, INC.—$14.55M135,9502.1%
← PrevPage 1 of 2Next →